Astrid Chevance

Publications

  • Veal C., Tomlinson A., Cipriani A., Bulteau S., Henry C., Muh C., Touboul S., De Waal N., Levy-Soussan H., Furukawa T-A, Fried E.I, Tran V-T., Chevance A., Heterogeneity of outcome measures in depression trials and the relevance of the content to patients: a systematic review, The Lancet Psychiatry, 2024 10.1016/S2215-0366(23)00438-8 (summarized in this blog post by Eiko Fried PhD)
  • Sahker E., Furukawa TA, Luo Y., Ferreira M-L, Okazaki K., Chevance A., Markham S., Ede R., Leucht S., Cipriani A., Salanti G., Estimating the smallest worthwhile difference of antidepressants: a cross-sectional survey, BMJ Ment Health 2024; 27:e300919. 10.1136/bmjment-2023-300919
  • Frajerman A, Chevance A, Chaumette B, Morvan Y. Prevalence and factors associated with depression and suicidal ideation among French students in 2016: A national study. Psychiatry Res 2023; 326: 115263. 10.1016/j.psychres.2023.115263
  • Martineau S, Cristea I-A, Chevance A, Fanelli D, Naudet F. Are large prospective trials on antidepressants in mental disorders seeding trials? A descriptive study of trials registered on ClinicalTrials.gov. BMJ Open 2023; 13: e062913. 10.1136/bmjopen-2022-062913
  • Jouannin A, Robin E, Bouvet S, et al. Validating a blood donation awareness tool created using general practitioner and patient acceptability and preferences. Transfus Clin Biol J Soc Francaise Transfus Sang 2023; 30: 103–10. 10.1016/j.tracli.2022.09.0670
  • Daouda OS, Chevance A, Temime L, et al. A new ranking index to identify the work-related psychosocial factors most impacting mental health: a cross-sectional study. BMJ Open 2022; 12: e046444. 10.1136/bmjopen-2020-046444
  • Charvet C., Boutron I., Morvan Y., Le Berre C., Touboul S., Gaillard R., Fried E., Chevance A., How to measure mental pain: a systematic review assessing measures of mental pain, Evid Based Ment Health. 2022 Nov;25(4):e4. DOI: 10.1136/ebmental-2021-300350
  • Chevance A., Tomlinson A., Ravaud P., Touboul S., Henshall C., Tran V-T, Cipriani A., Important Important adverse events to be evaluated in antidepressant trials and meta-analysis: a large international preference study, Evid Based Ment Health. 2022 Dec;25(e1):e41-e48 DOI: 10.1136/ebmental-2021-300418
  • Chevance A., Ravaud P., Cornelius V., Mayo-Wilson E., Furukawa T., Designing clinically useful psychopharmacological trials: challenges and ways forward, The Lancet Psychiatry, 2022 Jul;9(7):584-594 DOI: 10.1016/S2215-0366(22)00041-4
  • Chevance A., Fortel A., Jouannin, A., Denis F., Mamzer M-F., Ravaud Ph., Sidorkiewicz S., Acceptability of and willingness to take digital pills by patients, the public and healthcare professionals: qualitative content analysis of a large online survey of a representative sample, J Med Internet Res. 2022 Feb 18;24(2):e25597. DOI: 10.2196/25597
  • Chevance A., Ravaud P., Tomlinson A., Le Berre C., Teufer B., Touboul S., Fried E., Gartlehner G., Cipriani A., Tran V-T., Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international online survey, The Lancet Psychiatry, 2020; 7(8):692-702. DOI: 10.1016/S2215-0366(20)30191-7 (summarized in this blog post by Eiko Fried, PhD)
  • Chevance A, Tran V-T, Ravaud P. Controversy and Debate Series on Core Outcome Sets. Paper 1: Improving the generalizability and credibility of core outcome sets (COS) by a large and international participation of diverse stakeholders. J Clin Epidemiol. 2020; 125:206-212.e1. DOI: 10.1016/j.jclinepi.2020.01.004
  • Chevance A, Tran V-T, Ravaud P. Controversy and Debate Series on Core Outcome Sets. Paper 7: Response to comments on the paper 2-6 re « Improving the generalizability and credibility of Core Outcome Sets (COSs) by involving large international sample of participants ». J Clin Epidemiol. 2020;125:232-4. DOI: 10.1016/j.jclinepi.2020.06.019
  • Chevance A., Naudet F., Gaillard R., Porcher R., Ravaud P., «Power behind the throne: a clinical trial simulation study evaluating the impact of controllable design factors on the power of antidepressant trials”, International Journal of Methods in Psychiatric Research, 2019, DOI: 10.1002/mpr.1779
  • Chevance A., Daouda O., Morvan Y., Salvador A. Legeron P., Saporta G., Hocine N., Gaillard G.: «Impact of work-related psychosocial risk factors on mental health: A cross-sectional study in the French working population », Plos One, doi: 10.1371/journal.pone.0233472, 2020
  • Chevance A., Gourion D., Hoertel N., Llorca P-M., Thomas P., Bocher R., Moro M-R., Laprévote V., Benyamina A., Fossati P., Masson P., Leaune E., Leboyer M., Gaillard R., Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review. L’Encephale. 2020;46(3):193-201. DOI: 10.1016/j.encep.2020.04.005
  • Mengin A., Allé MC., Rolling J., Ligier F., Schroder C., Lalanne L., Berna F., Jardri R., Vaiva G., Geoffroy PA., Brunault P., Thibault F., Chevance A., Giersch A., [Psychopathological consequences of confinement]. L’Encephale. 2020;46(3S):S43-52. DOI: 10.1016/j.encep.2020.04.007
  • Hoertel N., Jaffré C., Pascal de Raykeer R., McMahon K., Barrière S., Blumenstock Y., Portefaix C., Raucher-Chené D., Béra-Potelle C., Cuervo-Lombard C. Chevance A., Guérin-Langlois C., Lemogne C., Airagnes G., Peyre H., Kaladjian A., Limosin F., CSA study group : « Subsyndromal and Syndromal Depressive Symptoms among Older Adults with Schizophrenia Spectrum Disorder: Prevalence and Associated Factors in a Multicenter Study ». Journal of Affective Disorders, 251, 2019: 60-70. DOI: https://doi.org/10.1016/j.jad.2019.03.007
  • Peyre H., Hoertel N., Rivollier F., Landman B., McMahon K., Chevance A., Lemogne C., Delorme R.,Blanco C., Limosin F.: « Latent Class Analysis of the Feared Situations of Social Anxiety Disorder: A Population-Based Study ». Depression and Anxiety 33, no 12 (2016): 1178-87. DOI: 10.1002/da.22547

Editorials

  • Morvan Y, Fried EI, Chevance A., Network modeling in psychopathology: Hopes and challenges. L’Encéphale, 2020;46(1):1-2 DOI: 10.1016/j.encep.2020.01.001
  • Kernot C, Tomlinson A, Chevance A, et al. One step closer to personalised prescribing of antidepressants: using real-world data together with patients and clinicians’ preferences. Evidence Based Mental Health 2019; 22:91–2. DOI: ​​10.1136/ebmental-2019-300105
  • Chevance A., Gaillard R. : « Éditorial. La dépression, du mal-être à la maladie ». Bulletin Epidémiologique Hebdomadaire, 2018;(32-33):636-7.

Medical Anthropology

  • Chevance A., Weber F., Comparative Methodological Perspectives on Clinical Interviews and Ethnographic Encounters with Persons Followed in Psychiatry, Anthropologie et Santé, 2020, DOI: 10.4000/anthropologiesante.5921
  • Chevance A., Weber F., Techniques (in) appropriées dans le champ du handicap psychique. Etat des lieux de l’usage des techniques dans le soin médical, l’accompagnement professionnel et l’aide bénévole., Actualités en MPR, 1-2/juin 2018
  • Marcel Mauss, Sociologie, psychologie, physiologie, Paris, PUF, coll. « Quadrige », 2021, 290 p., édition et présentation de Astrid Chevance, Julien Clément et Florence Weber, ISBN : 978-2-13-059529-8